Actemra Efficacy Persists at 1 Year

LIVERPOOL (MedPage Today) -- The comparable efficacy of subcutaneous tocilizumab (Actemra) and the intravenous formulation in patients with rheumatoid arthritis persisted for a year, with safety also being similar, a researcher reported here. via MedPageToday.com - medical news plus CME for physicians Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://ift.tt/1rGsE49